Your browser doesn't support javascript.
loading
Olfactory and Gustatory Dysfunction as An Early Identifier of COVID-19 in Adults and Children: An International Multicenter Study
Chenghao Qiu; Chong Cui; Charlotte Hautefort; Antje Haehner; Jun Zhao; Qi Yao; Hui Zeng; Eric J. Nisenbaum; Li Liu; Yu Zhao; Di Zhang; Corinna G. Levine; Ivette Cejas; Qi Dai; Mei Zeng; Philippe Herman; Clement Jourdaine; Katja de With; Julia Draf; Bing Chen; Dushyantha T. Jayaweera; James C. Denneny III; Roy Casiano; Hongmeng Yu; Adrien A. Eshraghi; Thomas Hummel; Xuezhong Liu; Yilai Shu; Hongzhou Lu.
Afiliação
  • Chenghao Qiu; Center of Stomatology, Shanghai Public Health Clinical Center, Shanghai 201508, China.
  • Chong Cui; ENT Institute and Otorhinolaryngology Department of the Affiliated Eye and ENT Hospital, State Key Laboratory of Medical Neurobiology, Institutes of Biomedical
  • Charlotte Hautefort; Department of Head and Neck Surgery, Hopital Lariboisiere, University of Paris, Paris, France.
  • Antje Haehner; Smell and Taste Clinic, Department of Otorhinolaryngology, TU Dresden, Dresden, Germany.
  • Jun Zhao; Center of Pediatrics, Shanghai Public Health Clinical Center, Shanghai 201508, China.
  • Qi Yao; Department of Otorhinolaryngology, Chinese and Western Medicine Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022
  • Hui Zeng; Department of Cardiovascularology, The Third People Hospital of Shenzhen, 29 Bulan Road, Longgang District, Shenzhen, 518112, China.
  • Eric J. Nisenbaum; Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Li Liu; Department of Infectious Diseases, Shanghai Public Health Clinical Center, 2901 Caolang Road, Shanghai 201508, China.
  • Yu Zhao; ENT Institute and Otorhinolaryngology Department of the Affiliated Eye and ENT Hospital, State Key Laboratory of Medical Neurobiology, Institutes of Biomedical
  • Di Zhang; Department of Otolaryngology, The Third People Hospital of Shenzhen, 29 Bulan Road, Longgang District, Shenzhen, 518112, China.
  • Corinna G. Levine; Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Ivette Cejas; Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Qi Dai; ENT Institute and Otorhinolaryngology Department of the Affiliated Eye and ENT Hospital, State Key Laboratory of Medical Neurobiology, Institutes of Biomedical
  • Mei Zeng; Department of Infectious Diseases, Children Hospital of Fudan University 399 Wanyuan Road, Shanghai, China, 201102.
  • Philippe Herman; Department of Head and Neck Surgery, Hopital Lariboisiere, University of Paris, Paris, France.
  • Clement Jourdaine; Department of Head and Neck Surgery, Hopital Lariboisiere, University of Paris, Paris, France.
  • Katja de With; Division of Infectious Diseases, University Hospital Carl Gustav Carus at the TU Dresden, Dresden, Germany
  • Julia Draf; Smell and Taste Clinic, Department of Otorhinolaryngology, TU Dresden, Dresden, Germany.
  • Bing Chen; ENT Institute and Otorhinolaryngology Department of the Affiliated Eye and ENT Hospital, State Key Laboratory of Medical Neurobiology, Institutes of Biomedical
  • Dushyantha T. Jayaweera; Department of Medicine, Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • James C. Denneny III; American Academy of Otolaryngology Head and Neck Surgery, Alexandria, Virginia, USA
  • Roy Casiano; Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Hongmeng Yu; ENT Institute and Otorhinolaryngology Department of the Affiliated Eye and ENT Hospital, State Key Laboratory of Medical Neurobiology, Institutes of Biomedical
  • Adrien A. Eshraghi; Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Thomas Hummel; Smell and Taste Clinic, Department of Otorhinolaryngology, TU Dresden, Dresden, Germany.
  • Xuezhong Liu; Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Yilai Shu; ENT Institute and Otorhinolaryngology Department of the Affiliated Eye and ENT Hospital, State Key Laboratory of Medical Neurobiology, Institutes of Biomedical
  • Hongzhou Lu; Department of Infectious Diseases, Shanghai Public Health Clinical Center, 2901 Caolang Road, Shanghai 201508, China.
Preprint em Inglês | medRxiv | ID: ppmedrxiv-20100198
Artigo de periódico
Um artigo publicado em periódico científico está disponível e provavelmente é baseado neste preprint, por meio do reconhecimento de similaridade realizado por uma máquina. A confirmação humana ainda está pendente.
Ver artigo de periódico
ABSTRACT
ObjectiveEvaluate the prevalence and characteristics of olfactory or gustatory dysfunction in COVID-19 patients Study DesignMulticenter Case Series Setting5 tertiary care hospitals (3 in China, 1 in France, 1 in Germany) Subjects and Methods394 PCR confirmed COVID-19 positive patients were screened, and those with olfactory or gustatory dysfunction were included. Data including demographics, COVID-19 severity, patient outcome, and the incidence and degree of olfactory and/or gustatory dysfunction were collected and analyzed. The Questionnaire of Olfactory Disorders (QOD) and Visual Analogue Scale (VAS) were used to quantify olfactory and gustatory dysfunction respectively. All subjects at one hospital (Shanghai) without subjective olfactory complaints underwent objective testing. ResultsOf 394 screened subjects, 161 (41%) reported olfactory and/or gustatory dysfunction and were included. Incidence of olfactory and/or gustatory disorders in Chinese (n=239), German (n=39) and French (n=116) cohorts were 32%, 69%, and 49% respectively. The median age of included subjects was 39 years old, 92/161 (57%) were male, and 10/161 (6%) were children. Of included subjects, 10% had only olfactory or gustatory symptoms, and 19% had olfactory and/or gustatory complaints prior to any other COVID-19 symptom. Of subjects with objective olfactory testing, 10/90 demonstrated abnormal chemosensory function despite reporting normal subjective olfaction. 43% (44/102) of subjects with follow-up showed symptomatic improvement in olfaction or gustation. ConclusionsOlfactory and/or gustatory disorders may represent early or isolated symptoms of SARS-CoV-2 infection. They may serve as a useful additional screening criterion, particularly for the identification of patients in the early stages of infection.
Licença
cc_no
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Cohort_studies / Experimental_studies / Estudo observacional / Estudo prognóstico Idioma: Inglês Ano de publicação: 2020 Tipo de documento: Preprint
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Cohort_studies / Experimental_studies / Estudo observacional / Estudo prognóstico Idioma: Inglês Ano de publicação: 2020 Tipo de documento: Preprint
...